NCT04830501View on ClinicalTrials.gov

Study of the of the Safety and Tolerability of TT-00434 in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 12, 2021

Primary Completion Date

October 18, 2023

Study Completion Date

October 18, 2023

Conditions
Advanced Solid Tumors
Interventions
DRUG

TT-00434

Once daily \[QD\], 28 days/cycle.

Trial Locations (3)

Unknown

National Cheng Kung University Hospital, Tainan City

Taipei Medical University Hospital, Taipei

Tri-Service General Hospital, Taipei

All Listed Sponsors
lead

TransThera Sciences (Nanjing), Inc.

INDUSTRY